Covid-19 roundup: Mod­er­na sub­mits vac­cine for full ap­proval; WHO un­veils new Greek-based sys­tem for nam­ing vari­ants

Mod­er­na has ini­ti­at­ed its BLA sub­mis­sion process with the FDA to li­cense its Covid-19 vac­cine in adults 18 and old­er, the com­pa­ny an­nounced Tues­day.

The com­pa­ny will sub­mit da­ta on a rolling ba­sis with a re­quest for pri­or­i­ty re­view, Mod­er­na said. Cur­rent­ly, the jab is avail­able un­der EUA. And the sub­mis­sion comes amid sur­vey da­ta sug­gest­ing more Amer­i­cans may take a vac­cine that is for­mal­ly ap­proved by the FDA, rather than avail­able un­der emer­gency use.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER